For COPD, can electronic health record data predict 90-day post hospitalization mortality — and thereby serve as a risk stratification tool?
Should enteral or IV vitamin C become standard of care in the treatment of patients with sepsis?
TRAVERSE trial findings on the efficacy, safety, and OCS-sparring effect of dupilumab for severe OCS-dependent asthma were presented at ATS 2022.
What biologic therapies effectively treat airway hyperresponsiveness in asthma, and what do these therapies show about the underlying biology of asthma?
Is lung cancer screening using risk-based low-dose computer tomography a better predictor of lung cancer risk than age or pack/years of smoking?
Can pulmonary rehabilitation improve outcomes in patients post-COVID-19 who are experiencing persistent and debilitating respiratory and other symptoms?
Can the hyperpolarized xenon-129 transfer contrast MRI, which details ventilation and gas exchange, help to characterize successful vs unsuccessful endobronchial valve placements?
Does omalizumab therapy for patients with moderate to severe allergic asthma affect these patients’ use of antitussives?
Does ventilation with individualized PEEP combined with continuous CPAP immediately after extubation leads to better oxygenation than PEEP alone?
How do outcomes of endobronchial ultrasound-guided transbronchial fine needle aspiration differ in patients aged 65 or older vs those younger than 65?
Should patients with asthma or COPD have their inhaler regimens switched for nonclinical reasons? A systematic review examined real world evidence on this subject.
To what extent does depression influence asthma exacerbations? A population-based study presented at ATS 2022 examined the link between exacerbations and depression.
Is red blood cell distribution width a predictor of outcomes in patients with acute respiratory distress syndrome who are critically ill?
Among children with asthma, are inhaled corticosteroids effective in controlling wheezing that is associated with these children’s gut microbiome?
What is the risk of future COPD exacerbations, hospitalizations, and death among patients with COPD who had 1 or 0 exacerbation in the previous 12 months?
What is the effect of ICS/LABA controller therapy on asthma in patients with persistent cold airway hyperresponsiveness, and does the effect differ in patients who smoke?
Researchers explored whether a cohort of veterans had received the 3 consecutive annual lung cancer screenings recommended to reduce lung cancer mortality.
What is the difference in efficacy between mepolizumab and benralizumab, 2 biologics approved for the treatment of severe eosinophilic asthma?
What respiratory symptoms are associated with transitions to or from e-cigarettes and cigarettes, and how prevalent are these symptoms?